As of 2024-12-12, the Relative Valuation of Evelo Biosciences Inc (EVLO) is (55,145.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.32 USD, the upside of Evelo Biosciences Inc based on Relative Valuation is -17423587.9%.
The range of the Relative Valuation is (24,254.80) - (85,120.61) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.3x - 18.6x | 12.0x |
| Forward P/E multiples | 5.3x - 19.0x | 12.2x |
| Fair Price | (24,254.80) - (85,120.61) | (55,145.34) |
| Upside | -7663542.8% - -26894446.4% | -17423587.9% |
| Date | P/E |
| 2024-12-03 | -0.00 |
| 2024-12-02 | -0.00 |
| 2024-11-29 | -0.00 |
| 2024-11-27 | -0.00 |
| 2024-11-26 | -0.00 |
| 2024-11-25 | -0.00 |
| 2024-11-22 | -0.00 |
| 2024-11-21 | -0.00 |
| 2024-11-20 | -0.00 |
| 2024-11-19 | -0.00 |
| 2024-11-18 | -0.00 |
| 2024-11-15 | -0.00 |
| 2024-11-14 | -0.00 |
| 2024-11-13 | -0.00 |
| 2024-11-12 | -0.00 |
| 2024-11-11 | -0.00 |
| 2024-11-08 | -0.00 |
| 2024-11-07 | -0.00 |
| 2024-11-06 | -0.00 |
| 2024-11-05 | -0.00 |
| 2024-11-04 | -0.00 |
| 2024-11-01 | -0.00 |
| 2024-10-31 | -0.00 |
| 2024-10-30 | -0.00 |
| 2024-10-29 | -0.00 |
| 2024-10-28 | -0.00 |
| 2024-10-25 | -0.00 |
| 2024-10-22 | -0.00 |
| 2024-10-21 | -0.00 |
| 2024-10-18 | -0.00 |
| 2024-10-17 | -0.00 |
| 2024-10-16 | -0.00 |
| 2024-10-15 | -0.00 |
| 2024-10-14 | -0.00 |
| 2024-10-11 | -0.00 |
| 2024-10-10 | -0.00 |
| 2024-10-08 | -0.00 |
| 2024-10-07 | -0.00 |
| 2024-10-04 | -0.00 |
| 2024-10-02 | -0.00 |
| 2024-10-01 | -0.00 |
| 2024-09-27 | -0.00 |
| 2024-09-26 | -0.00 |
| 2024-09-25 | -0.00 |
| 2024-09-24 | -0.00 |
| 2024-09-23 | -0.00 |
| 2024-09-20 | -0.00 |
| 2024-09-19 | -0.00 |
| 2024-09-18 | -0.00 |
| 2024-09-17 | -0.00 |